Effects of ODM-109 on Respiratory Function in Patients With ALS

Status:

Open (Study open and enrolling)

ClinicalTrials.gov:

Effects of ODM-109 on Respiratory Function in Patients With ALS. A Randomized, Double Blind, Placebo-controlled, Cross-over, 3-period, Multicenter Study With Open-label Follow-up Extension

Drug

ODM-109

Trial Type

Observational

Age Range

18 years or older

Condition

Amyotrophic Lateral Sclerosis (ALS)

Keywords

Amyotrophic Lateral Sclerosis | ALS | respiratory function